Navigasi
Pandangan Pasar Penyaring Saham Kalender Dividen Kalender acara Peringkat saham Berita Pasar
Coba gratis

Axonics Modulation Technologies

NASDAQ AXNX
$67.55 -0.12 -0.18%
Today share price
Amerika Serikat
Sector: Healthcare Industry: Health Care Equipment & Supplies
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.44B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
3.34B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.19
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
50.93M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
8.55 %

Upcoming events Axonics Modulation Technologies

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Axonics Modulation Technologies

Stock analysis Axonics Modulation Technologies

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-215.66 55.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
5.40 18.85
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
185.25 39.77
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-5.72 0.81
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-2.54 18.00

Price change Axonics Modulation Technologies per year

41.13$ 79.81$
Min Max

Summary analysis Axonics Modulation Technologies

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Axonics Modulation Technologies

Revenue and net income Axonics Modulation Technologies

All parameters

Stock news Axonics Modulation Technologies

All news

About company Axonics Modulation Technologies

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.
Address:
26 Technology Drive, Irvine, CA, United States, 92618
Company name: Axonics Modulation Technologies
Issuer ticker: AXNX
ISIN: US05465P1012
Country: Amerika Serikat
Exchange: NASDAQ
Currency: $
IPO date: 2018-10-31
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.axonics.com

On which stock exchange are Axonics Modulation Technologies (AXNX) stocks traded?

Axonics Modulation Technologies (AXNX) stocks are traded on NASDAQ.

What is the ticker of Axonics Modulation Technologies stocks (AXNX)?

The stock ticker of Axonics Modulation Technologies’s stocks or in other words, the code is AXNX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Axonics Modulation Technologies (AXNX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Axonics Modulation Technologies (AXNX) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are Axonics Modulation Technologies (AXNX) stocks traded?

Axonics Modulation Technologies (AXNX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Axonics Modulation Technologies (AXNX) stocks today?

The current price of Axonics Modulation Technologies stocks on 18.05.2024 is 67.55 dollars. per share.

What is the dynamics of Axonics Modulation Technologies (AXNX) stocks from the beginning of the year?

Axonics Modulation Technologies (AXNX) quotes have increased by 13.13% from the beginning of the year up to 67.55 dollars. per 1 stocks.

How much did Axonics Modulation Technologies (AXNX) stocks increase in мае 2024?

This month Axonics Modulation Technologies (AXNX) quotes have increased by 1.02% to 67.55 dollars. per share.

How much are Axonics Modulation Technologies (AXNX) stocks worth?

Today, on October, 18.05.2024 Axonics Modulation Technologies’s (AXNX) stocks cost 67.55 dollars..

What is the market capitalization of Axonics Modulation Technologies (AXNX)?

Capitalization is the market value of Axonics Modulation Technologies (AXNX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.05.2024, the market capitalization of Axonics Modulation Technologies (AXNX) is estimated at about 3440197951 dollars.